Ampio says its study on Covid-19 patients proceeding to full open enrollment
Ampio Pharmaceuticals Inc has announced that its AP-014 Phase I inhaled Ampion clinical study in Covid-19 patients is proceeding to full open enrollment after...
ResMed announces expansion of AirView remote monitoring for ventilation in India
ResMed has announced expansion of AirView for Ventilation, its cloud-based remote monitoring and management platform for respiratory care patients, in India.
According to the leading...
NIH starts study of Covid infection and multisystem inflammatory syndrome
NIH has started an observational study has launched to evaluate the short- and long-term health outcomes of SARS-CoV-2 infection in children
This includes multisystem inflammatory...
Montefiore and Albert Einstein College of Medicine gets new Covid-19 vaccine unit
A new Covid-19 vaccine unit has been opened at Montefiore Health System and Albert Einstein College of Medicine. It will enroll people in clinical...
COMMUNITY: A global platform trial for hospitalised patients with Covid-19
Three members of the Covid Research & Development Alliance have announced the first patient enrolled in the Community Trial.
The three members are Amgen Inc,...
Drawbridge Health ties up with University of Cambridge researchers
Drawbridge Health and the Medical Research Council (MRC) Epidemiology Unit, University of Cambridge announced the use of the OneDraw Blood Collection Device for remote...
Haoma Medica’s novel treatment for osteoporosis, NaQuinate, undergoes first human trial
Haoma Medica has announced the completion of a first-in-human trial for NaQuinate. A naphthoquinone carboxylic acid, it is being developed as a novel orally...
Hydroxychloroquine doesn’t benefit adults hospitalised with Covid-19: NIH trial
A clinical trial by National Institutes of Health, evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with Covid-19, has concluded...
Covid-19 investigational therapeutics to be analysed in big clinical trials
Covid-19 investigational therapeutics are to be evaluated in large clinical trials. Two controlled, randomized Phase 3 clinical trials have started evaluating investigational monoclonal antibodies...
Neighbourhood conditions linked with cognitive function of children
A latest research suggests that children from poorer neighbourhoods perform less well on a range of cognitive functions.
The study has been published in JAMA...
